Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0192USD
−20.47 MUSD
8.01 MUSD
177.80 M
About ASCLETIS PHARMA INC
Sector
Industry
CEO
Jinzi J. Wu
Website
Headquarters
Hangzhou
Employees (FY)
219
Founded
2013
FIGI
BBG00QB9NND0
Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company was founded by Jinzi Jason Wu and is headquartered in Hangzhou, China.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ASCLF is 0.1514 USD — it has decreased by 25.16% in the past 24 hours. Watch Ascletis Pharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ascletis Pharma Inc. stocks are traded under the ticker ASCLF.
We've gathered analysts' opinions on Ascletis Pharma Inc. future price: according to them, ASCLF price has a max estimate of 0.49 USD and a min estimate of 0.28 USD. Watch ASCLF chart and read a more detailed Ascletis Pharma Inc. stock forecast: see what analysts think of Ascletis Pharma Inc. and suggest that you do with its stocks.
ASCLF reached its all-time high on Jul 13, 2021 with the price of 1.1400 USD, and its all-time low was 0.0004 USD and was reached on May 14, 2021. View more price dynamics on ASCLF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ASCLF stock is 37.19% volatile and has beta coefficient of 0.42. Track Ascletis Pharma Inc. stock price on the chart and check out the list of the most volatile stocks — is Ascletis Pharma Inc. there?
Today Ascletis Pharma Inc. has the market capitalization of 105.67 M, it has decreased by 4.38% over the last week.
Yes, you can track Ascletis Pharma Inc. financials in yearly and quarterly reports right on TradingView.
Ascletis Pharma Inc. is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
ASCLF earnings for the last half-year are −0.02 USD per share, whereas the estimation was −0.01 USD, resulting in a −70.69% surprise. The estimated earnings for the next half-year are −0.02 USD per share. See more details about Ascletis Pharma Inc. earnings.
Ascletis Pharma Inc. revenue for the last half-year amounts to 1.01 M USD, despite the estimated figure of 2.88 M USD. In the next half-year revenue is expected to reach 0 USD.
ASCLF net income for the last half-year is −17.73 M USD, while the previous report showed −2.39 M USD of net income which accounts for −641.96% change. Track more Ascletis Pharma Inc. financial stats to get the full picture.
No, ASCLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 26, 2024, the company has 219.00 employees. See our rating of the largest employees — is Ascletis Pharma Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ascletis Pharma Inc. EBITDA is −40.30 M USD, and current EBITDA margin is −508.93%. See more stats in Ascletis Pharma Inc. financial statements.
Like other stocks, ASCLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ascletis Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ascletis Pharma Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ascletis Pharma Inc. stock shows the sell signal. See more of Ascletis Pharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.